After melanoma surgery, Bristol`s Opdivo offers new care standard

Published 7y ago

Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients who have had surgery to remove disease, researchers reported on Monday. More »